Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RPRX · against 1,372 other Healthcare companies
Ranked #952 of 1,373 · scores higher than 31% of peers · safety percentile 31
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 30–39, including RPRX · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.92× | 0.24× | 17% | 33% | |
| BetaLower is better · 1,320 reported | 0.43 | 0.53 | 57% | 33% | |
| Current ratioHigher is better · 1,338 reported | 2.80× | 2.62× | 52% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 948 | 35.2B JPY (≈$240M) | 31 | 12 | |
| 949 | 24.7B CNY (≈$3.5B) | 31 | 39 | |
| 950 | 354M USD | 31 | 13 | |
| 951 | 4.4B CHF (≈$5.1B) | 31 | 47 | |
| 952 | 38.4B USD | 31 | 50 | |
| 953 | 44.2B JPY (≈$301M) | 31 | 64 | |
| 954 | 3.5B CNY (≈$496M) | 31 | 18 | |
| 955 | 119.1B USD | 30 | 57 | |
| 956 | 45.6B CHF (≈$52.4B) | 30 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score